Total Payments
$195,857
2024 Payments
$29,305
Companies
16
Transactions
292
Payment Breakdown by Category
Consulting$101,565 (51.9%)
Other$36,070 (18.4%)
Research$24,520 (12.5%)
Travel$14,867 (7.6%)
Education$12,412 (6.3%)
Food & Beverage$6,422 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $101,565 | 40 | 51.9% |
| Unspecified | $24,520 | 22 | 12.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,460 | 9 | 11.0% |
| Travel and Lodging | $14,867 | 64 | 7.6% |
| Honoraria | $14,610 | 9 | 7.5% |
| Education | $12,412 | 52 | 6.3% |
| Food and Beverage | $6,422 | 96 | 3.3% |
Payments by Type
General
$171,337
270 transactions
Research
$24,520
22 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sarepta Therapeutics, Inc. | $50,968 | 67 | $0 (2024) |
| Biogen, Inc. | $47,943 | 73 | $0 (2024) |
| PFIZER INC. | $40,910 | 45 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $21,858 | 19 | $0 (2024) |
| AveXis | $12,997 | 45 | $0 (2019) |
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $7,401 | 15 | $0 (2021) |
| Genentech USA, Inc. | $4,665 | 2 | $0 (2021) |
| Vertex Pharmaceuticals Incorporated | $2,698 | 6 | $0 (2023) |
| Daiichi Sankyo Inc. | $2,243 | 2 | $0 (2020) |
| NS Pharma, Inc. | $1,876 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,305 | 22 | CATALYST PHARMACEUTICALS, INC. ($15,685) |
| 2023 | $29,770 | 56 | PFIZER INC. ($11,310) |
| 2022 | $37,119 | 50 | Sarepta Therapeutics, Inc. ($21,744) |
| 2021 | $7,368 | 11 | Genentech USA, Inc. ($2,735) |
| 2020 | $21,429 | 29 | Sarepta Therapeutics, Inc. ($9,565) |
| 2019 | $29,023 | 64 | AveXis ($12,997) |
| 2018 | $36,257 | 49 | Biogen, Inc. ($28,559) |
| 2017 | $5,585 | 11 | Biogen, Inc. ($5,493) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $56.43 | General |
| 09/23/2024 | PFIZER INC. | — | — | In-kind items and services | $780.00 | Research |
| Study: DOMAGROZUMAB CLINICAL PUBLICATION PROGRAM | ||||||
| 07/19/2024 | PFIZER INC. | — | — | In-kind items and services | $780.00 | Research |
| Study: DOMAGROZUMAB CLINICAL PUBLICATION PROGRAM | ||||||
| 05/20/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $80.10 | General |
| 05/17/2024 | CATALYST PHARMACEUTICALS, INC. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 05/14/2024 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: DOMAGROZUMAB CLINICAL PUBLICATION PROGRAM | ||||||
| 04/25/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $568.81 | General |
| Category: NEUROLOGY | ||||||
| 04/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 03/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Consulting Fee | Cash or cash equivalent | $7,800.00 | General |
| Category: NEUROLOGY | ||||||
| 03/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $677.26 | General |
| Category: NEUROLOGY | ||||||
| 03/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $486.20 | General |
| Category: NEUROLOGY | ||||||
| 03/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| Category: NEUROLOGY | ||||||
| 03/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $38.31 | General |
| Category: NEUROLOGY | ||||||
| 03/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $34.18 | General |
| Category: NEUROLOGY | ||||||
| 03/07/2024 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB MULTI PRODUCT PF06755347 CLINICAL PUBLICATION PROGRAM | ||||||
| 03/06/2024 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB MULTI PRODUCT PF06755347 CLINICAL PUBLICATION PROGRAM | ||||||
| 03/05/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $50.18 | General |
| 03/05/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $30.36 | General |
| 03/04/2024 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: NONCOVERED PRODUCT CLINICAL PUBLICATION PROGRAM | ||||||
| 03/03/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Neurology | ||||||
| 02/05/2024 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB MULTI PRODUCT PF06755347 CLINICAL PUBLICATION PROGRAM | ||||||
| 02/01/2024 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB MULTI PRODUCT PF06755347 CLINICAL PUBLICATION PROGRAM | ||||||
| 12/18/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 12/15/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PF06755347 CLINICAL PUBLICATION PROGRAM | ||||||
| 11/04/2023 | Catalyst Pharmaceuticals, Inc. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $1,174.93 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB MULTI PRODUCT PF06755347 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $7,670 | 4 |
| DOMAGROZUMAB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,970 | 6 |
| RARE NEUROLOGY CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,070 | 6 |
| MULTI PRODUCT FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB PF06755347 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
| PF06755347 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
| NONCOVERED PRODUCT CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| FORDADISTROGENE MOVAPARVOVEC CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
About Dr. Edward Smith, MD
Dr. Edward Smith, MD is a Pediatrics healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1881897361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Smith, MD has received a total of $195,857 in payments from pharmaceutical and medical device companies, with $29,305 received in 2024. These payments were reported across 292 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($101,565).
Ad
Practice Information
- Specialty Pediatrics
- Location Durham, NC
- Active Since 06/11/2007
- Last Updated 10/05/2007
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1881897361
Products in Payments
- SPINRAZA (Biological) $47,433
- ZOLGENSMA (Biological) $20,262
- AGAMREE (Drug) $15,684
- Exondys 51 (Drug) $6,565
- EXONDYS 51 (Drug) $6,277
- Evrysdi (Drug) $4,796
- VILTEPSO (Drug) $1,326
- FIRDAPSE (Drug) $173.51
- Soliris (Drug) $150.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Durham
Dwight Koeberl
Pediatrics — Payments: $8.4M
Pediatrics $8.4M
Priya Kishnani
Pediatrics — Payments: $5.9M
Pediatrics $5.9M
John Sleasman, Md, MD
Pediatrics — Payments: $322,883
Pediatrics $322,883
Dr. Muhammad Zafar, M.d, M.D
Pediatrics — Payments: $158,957
Pediatrics $158,957
Jennifer Li, Md, MD
Pediatrics — Payments: $55,856
Pediatrics $55,856
Sarah Armstrong, Md, MD
Pediatrics — Payments: $46,142
Pediatrics $46,142